| Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report MN Hill, GE Miller, WSV Ho, BB Gorzalka, CJ Hillard Pharmacopsychiatry 41 (02), 48-53, 2008 | 333 | 2008 |
| ‘Entourage’effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors WSV Ho, DA Barrett, MD Randall British journal of pharmacology 155 (6), 837-846, 2008 | 299 | 2008 |
| Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice DJ Rademacher, SE Meier, L Shi, WS Vanessa Ho, A Jarrahian, ... Neuropharmacology 54 (1), 108-116, 2008 | 287 | 2008 |
| Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic–pituitary … MN Hill, WSV Ho, KJ Sinopoli, V Viau, CJ Hillard, BB Gorzalka Neuropsychopharmacology 31 (12), 2591-2599, 2006 | 142 | 2006 |
| The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity S Patel, EJ Carrier, WSV Ho, DJ Rademacher, S Cunningham, DS Reddy, ... Journal of lipid research 46 (2), 342-349, 2005 | 136 | 2005 |
| Mechanisms of anandamide‐induced vasorelaxation in rat isolated coronary arteries R White, WS Vanessa Ho, FE Bottrill, WR Ford, CR Hiley British journal of pharmacology 134 (4), 921-929, 2001 | 132 | 2001 |
| Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus MN Hill, EJ Carrier, WSV Ho, L Shi, S Patel, BB Gorzalka, CJ Hillard Hippocampus 18 (2), 221-226, 2008 | 110 | 2008 |
| Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents MN Hill, WSV Ho, CJ Hillard, BB Gorzalka Journal of neural transmission 115 (12), 1673-1679, 2008 | 91 | 2008 |
| Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery WS Vanessa Ho, CR Hiley British journal of pharmacology 138 (7), 1320-1332, 2003 | 87 | 2003 |
| Endothelium‐dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2‐arachidonoylglycerol WS Ho, MD Randall British journal of pharmacology 150 (5), 641-651, 2007 | 74 | 2007 |
| N‐arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium‐activated potassium channels N Parmar, W Ho, S Vanessa British journal of pharmacology 160 (3), 594-603, 2010 | 69 | 2010 |
| Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity MN Hill, AM Barr, WSV Ho, EJ Carrier, BB Gorzalka, CJ Hillard Journal of neurochemistry 103 (1), 47-56, 2007 | 60 | 2007 |
| Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala MN Hill, WSV Ho, SE Meier, BB Gorzalka, CJ Hillard European journal of pharmacology 528 (1), 99-102, 2005 | 51 | 2005 |
| Endothelium‐independent relaxation to cannabinoids in rat‐isolated mesenteric artery and role of Ca2+ influx WS Vanessa Ho, C Robin Hiley British journal of pharmacology 139 (3), 585-597, 2003 | 50 | 2003 |
| Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats W Ho, S Vanessa, SM Gardiner British journal of pharmacology 156 (1), 94-104, 2009 | 48 | 2009 |
| Stimulation of calcium-sensing receptors induces endothelium-dependent vasorelaxations via nitric oxide production and activation of IKCa channels HZE Greenberg, J Shi, KS Jahan, MC Martinucci, SJ Gilbert, WSV Ho, ... Vascular pharmacology 80, 75-84, 2016 | 42 | 2016 |
| Serum contents of endocannabinoids are correlated with blood pressure in depressed women WSV Ho, MN Hill, GE Miller, BB Gorzalka, CJ Hillard Lipids in health and disease 11 (1), 1-9, 2012 | 42 | 2012 |
| Vascular actions of calcimimetics: role of Ca2+‐sensing receptors versus Ca2+ influx through L‐type Ca2+ channels P Thakore, W Ho, S Vanessa British journal of pharmacology 162 (3), 749-762, 2011 | 40 | 2011 |
| Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery WSV Ho, CR Hiley Journal of pharmacy and pharmacology 56 (7), 869-875, 2004 | 39 | 2004 |
| Modulators of endocannabinoid enzymic hydrolysis and membrane transport WSV Ho, CJ Hillard Cannabinoids, 187-207, 2005 | 35 | 2005 |
David RademacherLoyola University Chicago在 luc.edu 的电子邮件经过验证
